EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Towards alpha-blockade–free surgery for pheochromocytoma and paraganglioma: experience from a newly established adrenal center

P Knyazeva, A Meyer, S C Thal, T Bachmann, P Goretzki, P F Alesina

Langenbeck's Archives of Surgery · 16.11.2026 · 412 (1)

DOI: 10.1007/s00423-026-04367-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Langenbeck's Archives of Surgery, online erschienen am 16.11.2026. Verfasst von P Knyazeva und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine Surgery, Helios University Hospital, Wuppertal, Germany. polinakn@gmail.com. Hauptthemen laut MEDLINE: Pheochromocytoma, Adrenal Gland Neoplasms, Paraganglioma, Adrenalectomy. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Private Universität Witten/Herdecke gGmbH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pheochromocytomas are rare catecholamine-secreting tumors for which surgical resection is the definitive treatment. Traditionally, preoperative alpha-adrenergic blockade is strictly recommended. However, recent evidence has questioned its necessity. In this study, we report our experience with pheochromocytoma surgery at a newly established adrenal center without prior specialization in adrenal surgery. Patients and methods From May 2022 to May 2026, 18 patients (14 female, 4 male; median age 63.1 years, interquartile range (IQR) 46.2–70.1) with catecholamine-producing tumors (15 pheochromocytomas and 3 paragangliomas) underwent surgical resection in our institution. Seventeen patients did not receive any preoperative alpha-adrenergic blockade, whereas one patient underwent surgery while already receiving phenoxybenzamine therapy initiated by the referral physician prior to admission. Intraoperative management included general anaesthesia, central venous access, and invasive arterial blood pressure monitoring. Urapidil and/or nitroglycerin were used as the primary antihypertensive agents. Data were prospectively collected and retrospectively analyzed, including patient demographics, preoperative metanephrine and normetanephrine secretion, intraoperative treatment of hypertension and hypotension, and postoperative outcomes.

Results

The median operative time was 49.5 min (IQR, 30–90). Sixteen procedures were performed minimally invasively (15 retroperitoneoscopic and one laparoscopic), and two by open approach. Partial adrenalectomy was performed in seven cases. Histology confirmed chromaffin cell tumors in all cases, with a median tumor size of 4.0 cm (IQR 3.15–5.15). Median peak intraoperative systolic blood pressure was 195 mmHg (IQR, 166–200). For intraoperative blood pressure control, urapidil was administered to 4 patients (22.2%), nitroglycerin to 3 (16.7%), and both agents to 3 (16.7%). The remaining 8 patients (44.4%), did not require pharmacological treatment. Ten patients (55.6%) had a maximum intraoperative noradrenaline requirement < 0.2 µg/kg/min, 5 (27.8%) required intermediate doses of 0.2–0.4 µg/kg/min, and 3 (16.7%) required high doses > 0.4 µg/kg/min. Median postoperative hospital stay was 2 days (IQR, 2–3). Two patients developed transient atrial fibrillation. No major complications or mortality occurred.

Conclusion

Our results support the feasibility of alpha-blockade-free surgery for pheochromocytoma, even in centers with limited prior experience in pheochromocytoma surgery. Education of the anaesthesiology team, structured perioperative protocols, and close interdisciplinary collaboration appear to be important for ensuring safe perioperative management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PheochromocytomaAdrenal Gland NeoplasmsParagangliomaAdrenalectomyHumansFemaleMiddle AgedMaleRetrospective StudiesAdrenergic alpha-AntagonistsAgedTreatment Outcome

Stichwörter der Autor:innen

AdrenalAdrenalectomyAlpha-blockadeParagangliomaPartial adrenalectomyPheochromocytoma

Substanzen

Adrenergic alpha-Antagonists

Autor:innen und Institutionen

  • Department of Endocrine Surgery, Helios University Hospital, Wuppertal, Germany. polinakn@gmail.com.
  • Department of Medicine, Universität Witten-Herdecke, Witten, Germany. polinakn@gmail.com.
  • Department of Endocrine Surgery, Helios University Hospital, Wuppertal, Germany.
  • Department of Medicine, Universität Witten-Herdecke, Witten, Germany.
  • Department of Anaesthesiology, Helios University Hospital, Wuppertal, Germany.
  • Department of Surgery, Center of Minimally Invasive Surgery, Evang. Kliniken Essen-Mitte, Essen, Germany.

Förderung

  • Private Universität Witten/Herdecke gGmbH

Zitieren

APA

Knyazeva, P., Meyer, A., Thal, S. C., Bachmann, T., Goretzki, P., & Alesina, P. F. (2026). Towards alpha-blockade–free surgery for pheochromocytoma and paraganglioma: experience from a newly established adrenal center. Langenbeck's Archives of Surgery, 412(1). https://doi.org/10.1007/s00423-026-04367-x

Vancouver

Knyazeva P, Meyer A, Thal SC, Bachmann T, Goretzki P, Alesina PF. Towards alpha-blockade–free surgery for pheochromocytoma and paraganglioma: experience from a newly established adrenal center. Langenbeck's Archives of Surgery. 2026;412(1). doi:10.1007/s00423-026-04367-x

BibTeX
@article{Knyazeva2026,
  author = {Knyazeva, P and Meyer, A and Thal, S C and Bachmann, T and Goretzki, P and Alesina, P F},
  title = {Towards alpha-blockade–free surgery for pheochromocytoma and paraganglioma: experience from a newly established adrenal center},
  journal = {Langenbeck's Archives of Surgery},
  year = {2026},
  volume = {412},
  number = {1},
  doi = {10.1007/s00423-026-04367-x}
}
Kostenlos starten →